Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Jm, Le Doussal"'
Autor:
Gautherot E, Rouvier E, laurent daniel, Loucif E, Bouhou J, Manetti C, Martin M, Jm, Le Doussal, Barbet J
Publikováno v:
Europe PubMed Central
We have developed a pretargeting strategy, called the affinity enhancement system (AES), which uses bispecific antibodies to target radiolabeled bivalent haptens to tumor cells. The aim of this study was to evaluate the potential of the AES for the r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::8d6640a7d4bca087493083c33b809df2
https://pubmed.ncbi.nlm.nih.gov/10716323
https://pubmed.ncbi.nlm.nih.gov/10716323
Autor:
Chajra H; Activen, Lausanne, Switzerland. chajra@activen-cosmetics.ch., Saguet T; Activen, Lausanne, Switzerland., Granger C; Stella Polaris Europe, Paris, France., Breton L; CILIA Consulting, Paris, France., Pinto PC; PhD Trials, Av. Maria Helena Vieira da Silva 24A, 1750-182, Lisbon, Portugal., Machicoane M; Activen, Lausanne, Switzerland., Le Doussal JM; Activen, Lausanne, Switzerland.
Publikováno v:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2024 Nov; Vol. 14 (11), pp. 2951-2952.
Autor:
Chajra H; Activen, Lausanne, Switzerland. chajra@activen-cosmetics.ch., Saguet T; Activen, Lausanne, Switzerland., Granger C; Stella Polaris Europe, Paris, France., Breton L; CILIA Consulting, Paris, France., Pinto PC; PhD Trials, Av. Maria Helena Vieira da Silva 24A, 1750-182, Lisbon, Portugal., Machicoane M; Activen, Lausanne, Switzerland., Le Doussal JM; Activen, Lausanne, Switzerland.
Publikováno v:
Dermatology and therapy [Dermatol Ther (Heidelb)] 2024 Nov; Vol. 14 (11), pp. 2929-2950. Date of Electronic Publication: 2024 Sep 19.
Autor:
Kasprowicz A; Univ Lille, CNRS, UMR 8576 - UGSF - Unité de Glycosbiologie Structurale et Fonctionnelle, 59655, Villeneuve d'Ascq, France.; OGD2Pharma, Institut de Recherche en Santé IRS2 - Nantes Biotech, Boulevard Benoni Goullin, 44200, Nantes, France., Cavdarli S; Univ Lille, CNRS, UMR 8576 - UGSF - Unité de Glycosbiologie Structurale et Fonctionnelle, 59655, Villeneuve d'Ascq, France., Delannoy P; Univ Lille, CNRS, UMR 8576 - UGSF - Unité de Glycosbiologie Structurale et Fonctionnelle, 59655, Villeneuve d'Ascq, France., Le Guezennec X; Institute of Molecular and Cell Biology (IMCB), Agency for Science, Technology and Research (A*STAR), 61 Biopolis Drive, Proteos, Singapore, 138673, Republic of Singapore., Defebvre C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, 59000, Lille, France., Spriet C; Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, US 41 - UAR 2014 - PLBS, 59000, Lille, France., Jonckheere N; Univ Lille, CNRS, Inserm, CHU Lille, Institut de Recherche Contre Le Cancer de Lille, UMR9020 - UMR-S 1277 - Canther Cancer Heterogeneity, Plasticity and Resistance to Therapies, 59000, Lille, France., Le Doussal JM; OGD2Pharma, Institut de Recherche en Santé IRS2 - Nantes Biotech, Boulevard Benoni Goullin, 44200, Nantes, France., Krzewinski-Recchi MA; Univ Lille, CNRS, UMR 8576 - UGSF - Unité de Glycosbiologie Structurale et Fonctionnelle, 59655, Villeneuve d'Ascq, France., Mitra S; Univ Lille, CNRS, Inserm, CHU Lille, Institut de Recherche Contre Le Cancer de Lille, UMR9020 - UMR-S 1277 - Canther Cancer Heterogeneity, Plasticity and Resistance to Therapies, 59000, Lille, France., Meignan S; Univ Lille, CNRS, Inserm, CHU Lille, Institut de Recherche Contre Le Cancer de Lille, UMR9020 - UMR-S 1277 - Canther Cancer Heterogeneity, Plasticity and Resistance to Therapies, 59000, Lille, France.; Tumorigenesis and Resistance to Treatment Unit, Centre Oscar Lambret, 59000, Lille, France., Groux-Degroote S; Univ Lille, CNRS, UMR 8576 - UGSF - Unité de Glycosbiologie Structurale et Fonctionnelle, 59655, Villeneuve d'Ascq, France. sophie.groux-degroote@univ-lille.fr.
Publikováno v:
Molecular and cellular biochemistry [Mol Cell Biochem] 2024 Oct 12. Date of Electronic Publication: 2024 Oct 12.
Autor:
Machicoane M; Fastox Pharma SA, Lausanne, Switzerland., Tonellato M; Department of Biomedical Sciences, University of Padova, Padova, Italy., Zainotto M; Department of Biomedical Sciences, University of Padova, Padova, Italy., Onillon P; Fastox Pharma SA, Lausanne, Switzerland., Stazi M; Department of Biomedical Sciences, University of Padova, Padova, Italy., Corso MD; Department of Biomedical Sciences, University of Padova, Padova, Italy., Megighian A; Department of Biomedical Sciences, University of Padova, Padova, Italy.; Padova Neuroscience Center, University of Padova, Padova, Italy., Rossetto O; Department of Biomedical Sciences, University of Padova, Padova, Italy.; Institute of Neuroscience, Italian Research Council, University of Padova, Padova, Italy.; Interdepartmental Research Center of Myology CIR-Myo, University of Padova, Padova, Italy., Le Doussal JM; Fastox Pharma SA, Lausanne, Switzerland., Pirazzini M; Department of Biomedical Sciences, University of Padova, Padova, Italy.; Interdepartmental Research Center of Myology CIR-Myo, University of Padova, Padova, Italy.
Publikováno v:
British journal of pharmacology [Br J Pharmacol] 2024 Oct 10. Date of Electronic Publication: 2024 Oct 10.
Role of Sialyl- O -Acetyltransferase CASD1 on GD2 Ganglioside O -Acetylation in Breast Cancer Cells.
Autor:
Cavdarli S; Univ Lille, CNRS, UMR 8576-UGSF- Unité de Glycosylation Structurale et Fonctionnelle, 59655 Villeneuve d'Ascq, France., Schröter L; Institute of Clinical Biochemistry, Hannover Medical School, 30623 Hannover, Germany., Albers M; Institute of Clinical Biochemistry, Hannover Medical School, 30623 Hannover, Germany., Baumann AM; Institute of Clinical Biochemistry, Hannover Medical School, 30623 Hannover, Germany., Vicogne D; Univ Lille, CNRS, UMR 8576-UGSF- Unité de Glycosylation Structurale et Fonctionnelle, 59655 Villeneuve d'Ascq, France., Le Doussal JM; OGD2 Pharma, IRS2-Nantes BIOTECH, 44200 Nantes, France., Mühlenhoff M; Institute of Clinical Biochemistry, Hannover Medical School, 30623 Hannover, Germany., Delannoy P; Univ Lille, CNRS, UMR 8576-UGSF- Unité de Glycosylation Structurale et Fonctionnelle, 59655 Villeneuve d'Ascq, France., Groux-Degroote S; Univ Lille, CNRS, UMR 8576-UGSF- Unité de Glycosylation Structurale et Fonctionnelle, 59655 Villeneuve d'Ascq, France.
Publikováno v:
Cells [Cells] 2021 Jun 11; Vol. 10 (6). Date of Electronic Publication: 2021 Jun 11.
Autor:
Cavdarli S; Univ. Lille, CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France.; OGD2 Pharma, Institut de Recherche en Santé de l'Université de Nantes, 44007 Nantes, France., Yamakawa N; Univ. Lille, CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France., Clarisse C; Univ. Lille, CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France., Aoki K; Complex Carbohydrate Research Center, University of Georgia, Athens, GA 30602, USA., Brysbaert G; Univ. Lille, CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France., Le Doussal JM; OGD2 Pharma, Institut de Recherche en Santé de l'Université de Nantes, 44007 Nantes, France., Delannoy P; Univ. Lille, CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France., Guérardel Y; Univ. Lille, CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France., Groux-Degroote S; Univ. Lille, CNRS, UMR 8576-UGSF-Unité de Glycobiologie Structurale et Fonctionnelle, F-59000 Lille, France.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2020 Jan 06; Vol. 21 (1). Date of Electronic Publication: 2020 Jan 06.
Autor:
Cavdarli S; CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, University Lille, F-59000, Lille, France.; OGD2 Pharma, Institut de Recherche en Santé de l'Université de Nantes, 44007, Nantes, France., Dewald JH; CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, University Lille, F-59000, Lille, France., Yamakawa N; CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, University Lille, F-59000, Lille, France., Guérardel Y; CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, University Lille, F-59000, Lille, France., Terme M; OGD2 Pharma, Institut de Recherche en Santé de l'Université de Nantes, 44007, Nantes, France., Le Doussal JM; OGD2 Pharma, Institut de Recherche en Santé de l'Université de Nantes, 44007, Nantes, France., Delannoy P; CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, University Lille, F-59000, Lille, France., Groux-Degroote S; CNRS, UMR 8576 - UGSF - Unité de Glycobiologie Structurale et Fonctionnelle, University Lille, F-59000, Lille, France. sophie.groux-degroote@univ-lille.fr.
Publikováno v:
Glycoconjugate journal [Glycoconj J] 2019 Feb; Vol. 36 (1), pp. 79-90. Date of Electronic Publication: 2019 Jan 05.
Autor:
Bertucci F; Department of Molecular Oncology, Centre de Recherche en Cancérologie de Marseille, UMR1068 Inserm, Institut Paoli-Calmettes IPC, 13273 Marseille, France. bertuccif@ipc.unicancer.fr, Finetti P, Roche H, Le Doussal JM, Marisa L, Martin AL, Lacroix-Triki M, Blanc-Fournier C, Jacquemier J, Peyro-Saint-Paul H, Viens P, Sotiriou C, Birnbaum D, Penault-Llorca F
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2013 Mar; Vol. 24 (3), pp. 625-32. Date of Electronic Publication: 2012 Nov 01.
Autor:
Bertucci F; Département d'Oncologie Moléculaire, Centre de Recherche en Cancérologie de Marseille, UMR891 Inserm, Institut Paoli-Calmettes (IPC), Marseille, France. bertuccif@marseille.fnclcc.fr, Borie N, Roche H, Bachelot T, Le Doussal JM, Macgrogan G, Debono S, Martinec A, Treilleux I, Finetti P, Esterni B, Extra JM, Geneve J, Hermitte F, Chabannon C, Jacquemier J, Martin AL, Longy M, Maraninchi D, Fert V, Birnbaum D, Viens P
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2011 Jun; Vol. 127 (2), pp. 363-73. Date of Electronic Publication: 2010 Jun 29.